Traumatic Brain Injury – Epidemiology – Mature Markets

DRG Epidemiology’s coverage of traumatic brain injury (TBI) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan). We report the number of ED admissions and hospitalizations for TBI in each country as well as annualized events projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets covered in this report.

DRG Epidemiology’s TBI forecast will answer the following questions:

  • What is the incidence of TBI ED and hospital admissions in the mature markets, and how does it vary by country?
  • In the population diagnosed with TBI, what is the severity of these events?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of TBI over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

In addition to the number of ED and hospital admissions for each forecast year, DRG Epidemiology provides at least ten years of forecast data for the following TBI subpopulations:

  • Severity status.

Note: Coverage may vary by country.